GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 with IC50s of 0

with IC50s of 0

PF-4800567 shows inhibitory activity against CK1ϵ and CK1δ in whole cells

3)27-14-15-12-22(17-6-4-5-7-18(17)23(15)29)28-20-10-11-26-21-13-16(25)8-9-19(20)21

epi-Gallocatechin

16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H

GAP-134 - CAS# 943134-39-2 Catalog No.:M10439-2 with IC50s of 0Danegaptide, also known as GAP 134 and ZP1609, is an orally active small molecule gap junction modifier for the treatment of atrial fibrillation. Danegaptide mproves conduction and reduces atrial fibrillation flutter in the canine sterile pericarditis model. Danegaptide prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia reperfusion injury in open chest dogs. Product information CAS Number: 943134 39 2